The psychological impact of a pilot whole-body screening trial (SMOC) on individuals with Li-Fraumeni syndrome

Kate A. McBride, Mary-Anne Young, Timothy E. Schlub, Mandy L. Ballinger, Judy Kirk, Martin H. Tattersall, David M. Thomas, Gillian Mitchell

Research output: Contribution to journalArticlepeer-review

Abstract

Individuals who have a germline TP53 mutation have Li‐Fraumeni Syndrome (LFS) and a high risk of cancer‐related morbidity and mortality. Effective cancer risk management is an important issue. A whole‐body (WB) surveillance trial (SMOC) in adults with TP53 mutations has been established to estimate the prevalence and incidence of investigable lesions in these carriers. The psychosocial impact of using WB MRI in individuals with LFS is unknown.
Original languageEnglish
Article number329
Pages (from-to)166-167
Number of pages2
JournalAsia Pacific Journal of Clinical Oncology
Volume10
Issue numberS8
DOIs
Publication statusPublished - 2014

Keywords

  • cancer
  • medical screening
  • psychological aspects

Fingerprint

Dive into the research topics of 'The psychological impact of a pilot whole-body screening trial (SMOC) on individuals with Li-Fraumeni syndrome'. Together they form a unique fingerprint.

Cite this